Daiwa Securities Group
MDGL icon

Daiwa Securities Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Daiwa Securities Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$452K Buy
897
+150
+20% +$79.3K ﹤0.01% 980
2026
Q2 		$401K Sell
747
-20
-3% -$10.2K ﹤0.01% 1004
2026
Q1 		$402K Buy
767
+699
+1,028% +$334K ﹤0.01% 946
2025
Q4 		$40K Sell
68
-2
-3% -$1.02K ﹤0.01% 1132
2025
Q3 		$32K Sell
70
-7
-9% -$2.61K ﹤0.01% 1118
2025
Q2 		$23K Buy
77
+5
+7% +$1.49K ﹤0.01% 1095
2025
Q1 		$24K Hold
72
– – ﹤0.01% 1065
2024
Q4 		$22K Sell
72
-11
-13% -$3.09K ﹤0.01% 1084
2024
Q3 		$18K Buy
83
+9
+12% +$2.3K ﹤0.01% 1104
2024
Q2 		$21K Hold
74
– – ﹤0.01% 1132
2024
Q1 		$20K Sell
74
-7
-9% -$1.65K ﹤0.01% 1137
2023
Q4 		$19K Buy
81
+12
+17% +$2.1K ﹤0.01% 1130
2023
Q3 		$10K Hold
69
– – ﹤0.01% 1125
2023
Q2 		$16K Hold
69
– – ﹤0.01% 1114
2023
Q1 		$17K Hold
69
– – ﹤0.01% 1084
2022
Q4 		$20K Buy
69
+12
+21% +$1.17K ﹤0.01% 1082
2022
Q3 		$4K Hold
57
– – ﹤0.01% 1177
2022
Q2 		$4K Hold
57
– – ﹤0.01% 1184
2022
Q1 		$6K Hold
57
– – ﹤0.01% 1161
2021
Q4 		$5K Hold
57
– – ﹤0.01% 1200
2021
Q3 		$5K Buy
57
+28
+97% +$2.42K ﹤0.01% 1177
2021
Q2 		$3K Hold
29
– – ﹤0.01% 1112
2021
Q1 		$3K Hold
29
– – ﹤0.01% 1111
2020
Q4 		$3K Buy
+29
New +$3.54K ﹤0.01% 1090

Other funds holding MDGL

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return

Daiwa Securities Group's MDGL Position: Q3 2026 in Review

Daiwa Securities Group increased its Madrigal Pharmaceuticals (MDGL) stake by 20% in Q3 2026, buying an estimated $79.3K and bringing the position to 897 shares worth $452K. The position accounts for ﹤0.01% of the portfolio, ranked #980.

Daiwa Securities Group first reported a position in MDGL in Q4 2020 and has held it in 24 quarters since. 332 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • Daiwa Securities Group held 897 shares of Madrigal Pharmaceuticals worth $452K as of Q3 2026.
  • Daiwa Securities Group bought 150 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $79.3K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Daiwa Securities Group's portfolio in Q3 2026, its #980 holding.
  • Daiwa Securities Group first reported a position in Madrigal Pharmaceuticals in Q4 2020 and has held it in 24 quarters since.
  • 332 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on Daiwa Securities Group's 13F filing for Q3 2026, filed 29 Oct 2026.